Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Restoring body image after cancer (ReBIC): A group therapy intervention.

Esplen MJ, Warner E, Boquiren V, Wong J, Toner B.

Psychooncology. 2020 Jan 26. doi: 10.1002/pon.5304. [Epub ahead of print]

PMID:
31984589
2.

Infant feeding among women with a history of breast cancer.

Azulay Chertok IR, Wolf JH, Beigelman S, Warner E.

J Cancer Surviv. 2020 Jan 14. doi: 10.1007/s11764-019-00852-z. [Epub ahead of print]

PMID:
31933150
3.

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.

Poorvu PD, Gelber SI, Rosenberg SM, Ruddy KJ, Tamimi RM, Collins LC, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Jakubowski DM, Russell C, Winer EP, Partridge AH.

J Clin Oncol. 2019 Dec 6:JCO1901959. doi: 10.1200/JCO.19.01959. [Epub ahead of print]

PMID:
31809240
4.

Feasibility and acceptability of i-Restoring Body Image after Cancer (i-ReBIC): A pilot trial for female cancer survivors.

Trachtenberg L, Wong J, Rennie H, McLeod D, Leung Y, Warner E, Esplen MJ.

Psychooncology. 2019 Nov 14. doi: 10.1002/pon.5288. [Epub ahead of print]

PMID:
31724261
5.

The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients.

Speller B, Metcalfe K, Kennedy ED, Facey M, Greenblatt E, Scheer AS, Warner E, Joy AA, Wright FC, Baxter NN.

BMC Med Inform Decis Mak. 2019 Oct 28;19(1):203. doi: 10.1186/s12911-019-0912-y.

6.

Effect of a Knowledge-Translation Intervention on Breast Surgeons' Oncofertility Attitudes and Practices.

Warner E, Yee S, Seminsky M, Glass K, Foong S, Kennedy E, Narod S, Quan ML.

Ann Surg Oncol. 2019 Oct 28. doi: 10.1245/s10434-019-07972-x. [Epub ahead of print]

PMID:
31659644
7.

Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?

Komorowski AS, Warner E, MacKay HJ, Sahgal A, Pritchard KI, Jerzak KJ.

Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(18)30863-2. doi: 10.1016/j.clbc.2019.06.007. [Epub ahead of print]

PMID:
31447286
8.

Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.

Chiarelli AM, Blackmore KM, Muradali D, Done SJ, Majpruz V, Weerasinghe A, Mirea L, Eisen A, Rabeneck L, Warner E.

J Natl Cancer Inst. 2020 Feb 1;112(2):136-144. doi: 10.1093/jnci/djz079.

PMID:
31233143
9.

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer.

Warner E.

Cancers (Basel). 2018 Nov 30;10(12). pii: E477. doi: 10.3390/cancers10120477. Review.

10.

Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Kim SJ, Huzarski T, Gronwald J, Singer CF, Møller P, Lynch HT, Armel S, Karlan BY, Foulkes WD, Neuhausen SL, Senter L, Eisen A, Eng C, Panchal S, Pal T, Olopade O, Zakalik D, Lubinski J, Narod SA, Kotsopoulos J; Hereditary Breast Cancer Clinical Study Group .

Int J Epidemiol. 2018 Jun 1;47(3):987-997. doi: 10.1093/ije/dyy039.

11.

Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.

Torres S, Trudeau M, Gandhi S, Warner E, Verma S, Pritchard KI, Petrella T, Hew-Shue M, Chao C, Eisen A.

Oncologist. 2018 Jul;23(7):768-775. doi: 10.1634/theoncologist.2017-0346. Epub 2018 Jan 25.

12.

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.

Eisen A, Blackmore KM, Meschino WS, Muradali D, Carroll JC, Majpruz V, Warner E, Rabeneck L, Chiarelli AM.

Mol Genet Genomic Med. 2018 Mar;6(2):213-223. doi: 10.1002/mgg3.359. Epub 2018 Jan 25.

13.

Restoring Body Image After Cancer (ReBIC): Results of a Randomized Controlled Trial.

Esplen MJ, Wong J, Warner E, Toner B.

J Clin Oncol. 2018 Mar 10;36(8):749-756. doi: 10.1200/JCO.2017.74.8244. Epub 2018 Jan 22.

PMID:
29356610
14.

RE: Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

Ozturk Topcu T, Jerzak KJ, Warner E.

J Natl Cancer Inst. 2018 Aug 1;110(8):918. doi: 10.1093/jnci/djx290. No abstract available.

PMID:
29329411
15.

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.

Phi XA, Houssami N, Hooning MJ, Riedl CC, Leach MO, Sardanelli F, Warner E, Trop I, Saadatmand S, Tilanus-Linthorst MMA, Helbich TH, van den Heuvel ER, de Koning HJ, Obdeijn IM, de Bock GH.

Eur J Cancer. 2017 Nov;85:31-38. doi: 10.1016/j.ejca.2017.07.055. Review.

PMID:
28886475
16.

MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.

Nadler M, Al-Attar H, Warner E, Martel AL, Balasingham S, Zhang L, Lipton JH, Curpen B.

Breast. 2017 Aug;34:77-82. doi: 10.1016/j.breast.2017.04.005. Epub 2017 May 18.

PMID:
28527397
17.

Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health.

Hamer J, Warner E.

CMAJ. 2017 Feb 21;189(7):E268-E274. doi: 10.1503/cmaj.160464. Review. No abstract available.

18.

The effect of surgery type on survival and recurrence in very young women with breast cancer.

Quan ML, Paszat LF, Fernandes KA, Sutradhar R, McCready DR, Rakovitch E, Warner E, Wright FC, Hodgson N, Brackstone M, Baxter NN.

J Surg Oncol. 2017 Feb;115(2):122-130. doi: 10.1002/jso.24489. Epub 2017 Jan 5.

PMID:
28054348
19.

Ten-year survival in women with primary stage IV breast cancer.

Eng LG, Dawood S, Sopik V, Haaland B, Tan PS, Bhoo-Pathy N, Warner E, Iqbal J, Narod SA, Dent R.

Breast Cancer Res Treat. 2016 Nov;160(1):145-152. Epub 2016 Sep 14.

PMID:
27628191
20.

Oncofertility Knowledge, Attitudes, and Practices of Canadian Breast Surgeons.

Warner E, Yee S, Kennedy E, Glass K, Foong S, Seminsky M, Quan ML.

Ann Surg Oncol. 2016 Nov;23(12):3850-3859. Epub 2016 Jul 18.

PMID:
27431414

Supplemental Content

Loading ...
Support Center